Established 1999
123jump.com - U.S. Financial Information Archive: 90,000 Annual and 10-K reports – 20,000 Global news stories - 3,500 IPO reports - 1,700 - Earnings Calls – 320 Fund Interviews – 10-year Annual earnings on 4,500 stocks – 20 Quarterly earnings on 3,600 stocks – 1,800 IPO prospectuses – 1,200 Economic data releases
     
   
 

Dynavax Technologies Corp.(DVAX)

 
123Jump Rating: - Value Gap   Underwriters: Bear Stearns & Co. Inc.
      Deutsche Bank Sec.
Status: Priced   U.S. Bancorp Piper Jaffrey
 
Address: 2929 7th St., Ste. 100
 FiledDate: 10/24/2003
  Berkeley,
    
  CA 94710-2753
 Filed Price Range ($): $12.00-14.00
       
Telephone: 510-848-5100 Filed Offer Amount ($ Million): $45.00
       
Fax: 510-848-1327 Shares Offered (Millions): 6
       
Websites: www.dynavax.com Shares Outstanding (Millions):
       
Management: Arnold Oronsky, Chair.
 IPO Date: 02/19/2004
  Dino Dina, Pres./Dir./CEO
    
  Deborah Smeltzer, VP/CFO
 Final Offer Price ($): $8.00
       
Industry: Pharmaceuticals Final Offer Size (Millions of Shares): 0.00
       
Employees: 77 Final Offer Amount ($ Million): $0.00
       
Competitors: ALK-Abelló
 S-1 Forms:
  GlaxoSmithKline
    
  Merck
  
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Company Links
Corporate / History Profile Executives Products Services
Income Data 
Year Revenues Costs Oper Income Taxes Net Income EPS
1996 0.00 222 -222 0.00 -206 -1.89
1997 0.00 3746 -3746 0.00 -3505 -5.29
1998 0.00 7094 -7094 0.00 -6778 -6.64
1999 450 7445 -6995 0.00 -6559 -4.5
2000 1493 8076 -6583 0.00 -5916 -11.21
* Period Aug. 29, (Inception) to Dec. 31, 1996
** Nine Months ended September 30, 2000
 
 
© 1999-2008 123jump.com. All rights reserved